More interestingly, catalpol’s activation of JAK2/STAT3 signaling, elevating VEGF mRNA/protein levels by 2.1 fold, normalizing CBF heterogeneity, and improving post-stroke neurobehavioral outcomes (Dong et al., 2016). This evidence concerns the gene VEGFA and stroke disorder.